Moringa Supplements and Salmonella: The 2026 Outbreak Explained

Moringa oleifera — sometimes called the "miracle tree" or the "drumstick tree" — is native to the foothills of the Himalayas and has been cultivated across South Asia, sub-Saharan Africa, and Central America for generations. Its leaves are genuinely nutrient-dense, containing meaningful concentrations of vitamin A, vitamin C, potassium, calcium, and iron, along with antioxidant compounds and all nine essential amino acids. For communities in regions where food security is fragile, moringa has been an important nutritional resource for a very long time.

The Western supplement industry discovered moringa roughly a decade ago and marketed it aggressively as a superfood. Powdered moringa leaf, dried and ground, became a standard ingredient in "super greens" blends alongside spirulina, chlorella, and wheatgrass. Capsules and teas followed. The global moringa products market was valued at over $10 billion in 2023 and is projected to nearly double by 2032, driven largely by North American demand for premium wellness products.

The Cleveland Clinic notes that while moringa does contain beneficial nutrients, many of the specific health claims made by supplement manufacturers — from blood sugar control to anti-inflammatory effects — have limited clinical evidence behind them, and more research is needed before those claims can be treated as established fact. That gap between the hype and the evidence is a recurring theme in the supplement industry, and it is part of why moringa powder ended up in products sold on Amazon, TikTok Shop, eBay, and Shein with minimal consumer scrutiny of where the ingredient actually came from.

What made the early 2026 moringa situation particularly alarming was not one outbreak but two — running simultaneously, linked to separate products, caused by different strains of Salmonella, traced to the same underlying ingredient.

The January outbreak was the larger of the two. Between August and December 2025, people across the country began reporting Salmonella symptoms after using powdered green supplements. By the time the CDC closed the investigation in March 2026, 97 people in 32 states had been infected with Salmonella Typhimurium or Salmonella Newport, 26 had been hospitalized, and no deaths had been reported. The recalled products were Live it Up Super Greens (in original and wild berry flavors, with expiration dates running through January 2028) and Why Not Natural Pure Organic Moringa Green Superfood capsules. Both were sold primarily online.

The FDA's traceback investigation found a common manufacturer supplying moringa leaf powder to both companies. Lab testing detected the outbreak strain in two moringa leaf powder ingredient samples. The contamination had been sitting in products on shelves, in subscribers' pantries, and in the supply chain for months before the cluster of illnesses was large enough to trigger the alarm.

The February outbreak was smaller but significantly more alarming. In a separate investigation, the CDC identified seven people in seven states who had been infected with a different strain — Salmonella Newport — after taking Rosabella brand moringa powder capsules distributed by Ambrosia Brands LLC. Three were hospitalized. This outbreak was unrelated to the January one. But what the strain was carrying made it a medical first in the United States.

The Rosabella outbreak introduced something that food safety experts had been dreading: a strain of Salmonella carrying the NDM-1 carbapenemase gene.

To understand why that matters, you need to know how Salmonella infections are normally treated. Most cases are mild and resolve without antibiotics. But in severe infections — particularly in young children, the elderly, and people with weakened immune systems — doctors rely on a progression of antibiotic options. When first-line drugs fail, they escalate. The final backstop in that progression is a class of antibiotics called carbapenems (drugs like meropenem), reserved for the most serious cases where everything else has stopped working.

The Rosabella strain was resistant to all of it. Amoxicillin-clavulanic acid, ampicillin, azithromycin, ceftriaxone, ciprofloxacin, trimethoprim-sulfamethoxazole — all failed. And the carbapenems that would normally serve as last resort were also neutralized by the NDM-1 gene. The CDC described it as the first documented outbreak of Salmonella with an NDM-1 gene in the United States.

The clinical guidance from the CDC is stark: there are currently no evidence-based antibiotic recommendations for managing this strain. Physicians treating infected patients must rely on custom susceptibility testing for each individual case and consult infectious disease specialists to find anything that might work.

There is an additional layer of concern beyond the outbreak itself. The NDM-1 gene sits on a plasmid — a small, mobile piece of DNA that bacteria are extraordinarily good at sharing with each other. When a person ingests this strain, the bacteria enter the gut and can potentially transfer the resistance gene to the normal bacteria already living there. That means someone who recovers completely from the illness could unknowingly carry and potentially spread a carbapenem-resistance gene in their gut microbiome long after the infection has cleared.

Salmonella in a powdered herbal supplement might seem counterintuitive. Salmonella is associated with raw chicken, undercooked eggs, and unwashed produce — not a capsule of dried plant powder. But dried herbs, spices, and botanical powders have a well-documented history of Salmonella contamination, and the reasons are structural.

The key factor is how Salmonella behaves in low-moisture environments. Unlike in refrigerated foods or raw meat, where bacterial growth is the main concern, in dry powders the issue is survival. Salmonella can survive for months — sometimes years — in a desiccated state, lying dormant in spice powder, dried herb, or botanical blend, waiting to be rehydrated in a glass of water or a stomach's digestive fluids before resuming activity. A manufacturing process that does not include an adequate pathogen kill step (such as steam treatment or irradiation) will not eliminate contamination that entered with the raw material.

The moringa supply chain compounds this risk. Moringa leaf is primarily grown in South Asia, East Africa, and South America, often under agricultural conditions where soil contamination, water quality, and handling practices vary significantly. By the time a batch of dried leaf powder reaches a US supplement manufacturer, it may have changed hands multiple times — farm to processor to broker to contract manufacturer — with testing requirements varying at each step. The FDA confirmed that both companies in the January outbreak were drawing from the same supplier, meaning a single contaminated batch was distributed across two separate consumer-facing brands that appeared entirely unrelated.

The moringa outbreaks cannot be fully understood without acknowledging the regulatory framework — or the absence of one — that governs the dietary supplement industry in the United States.

Unlike pharmaceutical drugs, which must demonstrate safety and efficacy before they can be sold, dietary supplements are regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Under DSHEA, manufacturers do not need pre-market approval from the FDA. They do not need to prove a product works. They do not even need to notify the FDA that a new supplement exists before it hits the market. The burden falls on the FDA to demonstrate harm after the fact.

This means a product containing moringa leaf powder sourced from a foreign supplier with unknown bacterial testing records can reach a consumer's pantry through Amazon Prime with no independent verification that it is free of pathogens. The FDA has authority to require good manufacturing practices (cGMP) for supplements, and those regulations do require testing — but enforcement is resource-limited, and compliance varies widely across the thousands of supplement manufacturers operating in the US.

The result is a trust gap. Consumers assume that a product sold in a reputable online marketplace with a health-focused brand identity and a nutritional claims panel has been tested for safety. In most cases, that assumption is reasonable. In some cases, it is not.

The moringa outbreaks do not mean you need to throw out all your supplements. But they do point to specific, actionable steps that can reduce risk significantly.

Check the FDA and CDC recall lists. Both agencies maintain up-to-date recall databases. If you have any of the affected products at home — Live it Up Super Greens (all lots expiring August 2026 through January 2028), Why Not Natural Pure Organic Moringa (lot #A25G051), or Rosabella Moringa capsules — discard them immediately and clean any surfaces they contacted.

Look for third-party testing certifications. Organizations such as NSF International, USP (United States Pharmacopeia), Informed Sport, and ConsumerLab independently test supplements for contaminants including heavy metals and pathogens. A product bearing one of these seals has been verified by a body with no financial stake in the outcome. Not every safe supplement has a certification, but uncertified products carry more uncertainty.

Be skeptical of supply chain opacity. If a supplement's label does not disclose where the raw ingredient was sourced, and the brand's website has no information about its manufacturing or testing standards, that is a meaningful gap. Reputable supplement companies will typically document their cGMP compliance and third-party testing.

"Natural" does not mean safe. Moringa is a real plant with real nutrients. It is not a synthetic additive or a chemical compound invented in a laboratory. But natural origin does not confer microbiological safety. The contamination in these outbreaks came from the soil and agricultural environment where the plant grew — entirely natural sources of entirely real pathogens.

The first January outbreak has been closed by the CDC. The recalled products are no longer on the market, and the implicated manufacturer has been identified. The February Rosabella outbreak, while smaller, introduced a resistant strain that public health officials will be monitoring closely — not just for further cases but for any evidence of resistance gene spread.

The broader industry response remains to be seen. Unlike a ban on a synthetic food additive, there is no simple regulatory lever to pull here. The issue is not moringa itself but the conditions under which it can become contaminated and the supply chain steps where that contamination could be caught and wasn't. Improving those conditions requires investment in testing infrastructure that not every supplement manufacturer currently has.

For consumers, the practical lesson is clear: the wellness aisle does not come with the same guarantees as the rest of the grocery store. The ingredient might be genuine. The health claims might be optimistic. And the pathogen testing might not have happened at all.

When you're scanning ingredient labels on green powders, super greens blends, or capsule supplements, moringa may appear as "moringa leaf powder," "Moringa oleifera leaf," or simply "moringa extract." IngrediCheck lets you scan any product's barcode and instantly see the full ingredient list — so you can quickly spot moringa and any other flagged ingredients before they make it into your morning smoothie.

This article is for informational purposes only and should not be considered medical advice. If you believe you have been sickened by a recalled product, consult a healthcare professional and report the illness to your local health department.